Ed W. McLean

784 total citations
28 papers, 678 citations indexed

About

Ed W. McLean is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Ed W. McLean has authored 28 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 10 papers in Molecular Biology and 9 papers in Infectious Diseases. Recurrent topics in Ed W. McLean's work include HIV/AIDS drug development and treatment (9 papers), Adenosine and Purinergic Signaling (8 papers) and Synthesis and Characterization of Heterocyclic Compounds (7 papers). Ed W. McLean is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Adenosine and Purinergic Signaling (8 papers) and Synthesis and Characterization of Heterocyclic Compounds (7 papers). Ed W. McLean collaborates with scholars based in United States, Belgium and United Kingdom. Ed W. McLean's co-authors include James L. Kelley, Barrett R. Cooper, Richard G. Davis, F. E. SOROKO, Cecilia S. Koble, Carl A. Miller, Richard Hazen, James L. Howard, Joel V. Tuttle and Jan Balzarini and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical Sciences and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Ed W. McLean

26 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ed W. McLean United States 16 402 290 198 82 67 28 678
Anne M. Exall United Kingdom 16 403 1.0× 352 1.2× 184 0.9× 106 1.3× 49 0.7× 22 662
Georges Maury France 14 269 0.7× 328 1.1× 211 1.1× 73 0.9× 87 1.3× 67 618
Ugo Pradère France 11 447 1.1× 389 1.3× 294 1.5× 113 1.4× 55 0.8× 13 767
V. S. Bhadti United States 13 425 1.1× 180 0.6× 147 0.7× 58 0.7× 75 1.1× 28 690
Esmir Gunić United States 17 286 0.7× 254 0.9× 133 0.7× 71 0.9× 41 0.6× 25 793
Hiroki Kumamoto Japan 15 315 0.8× 225 0.8× 187 0.9× 79 1.0× 62 0.9× 54 551
Pamela Russ United States 14 373 0.9× 613 2.1× 305 1.5× 128 1.6× 70 1.0× 23 907
Stuart R. Michelson United States 16 394 1.0× 399 1.4× 188 0.9× 44 0.5× 140 2.1× 24 844
Bruce A. Dressman United States 12 713 1.8× 669 2.3× 230 1.2× 46 0.6× 168 2.5× 12 1.2k
Larryn W. Peterson United States 12 118 0.3× 316 1.1× 110 0.6× 64 0.8× 35 0.5× 39 498

Countries citing papers authored by Ed W. McLean

Since Specialization
Citations

This map shows the geographic impact of Ed W. McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed W. McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed W. McLean more than expected).

Fields of papers citing papers by Ed W. McLean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed W. McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed W. McLean. The network helps show where Ed W. McLean may publish in the future.

Co-authorship network of co-authors of Ed W. McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Ed W. McLean. A scholar is included among the top collaborators of Ed W. McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed W. McLean. Ed W. McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, John F., C. Webster Andrews, Eric S. Furfine, et al.. (2006). Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385. Bioorganic & Medicinal Chemistry Letters. 16(7). 1788–1794. 70 indexed citations
2.
McGuigan, Christopher, Sheila Srinivasan, Yikang Wang, et al.. (2006). Application of Phosphoramidate ProTide Technology Significantly Improves Antiviral Potency of Carbocyclic Adenosine Derivatives. Journal of Medicinal Chemistry. 49(24). 7215–7226. 51 indexed citations
3.
Musso, David L., Felicia R. Cochran, James L. Kelley, et al.. (2002). Indanylidenes. 1. Design and Synthesis of (E)-2-(4,6-Difluoro-1-indanylidene)acetamide, a Potent, Centrally Acting Muscle Relaxant with Antiinflammatory and Analgesic Activity. Journal of Medicinal Chemistry. 46(3). 399–408. 55 indexed citations
4.
Kelley, James L., Ed W. McLean, Ronald C. Crouch, D R Averett, & Joel V. Tuttle. (1995). [[(Guaninylalkyl)phosphinico]methyl]phosphonic Acids. Multisubstrate Analog Inhibitors of Human Erythrocyte Purine Nucleoside Phosphorylase. Journal of Medicinal Chemistry. 38(6). 1005–1014. 30 indexed citations
5.
Kelley, James L., Cecilia S. Koble, Richard G. Davis, et al.. (1995). 1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c]pyridines: Synthesis and Anticonvulsant Activity. Journal of Medicinal Chemistry. 38(20). 4131–4134. 109 indexed citations
6.
Kelley, James L., Richard G. Davis, Ed W. McLean, et al.. (1995). Synthesis and anticonvulsant activity of N-Benzylpyrrolo[2,3-d]-, -pyrazolo[3,4-d]-, and -triazolo[4,5-d]pyrimidines: imidazole ring-modified analogs of 9-(2-Fluorobenzyl)-6-(methylamino)-9H-purine. Journal of Medicinal Chemistry. 38(19). 3884–3888. 20 indexed citations
8.
Kelley, James L., et al.. (1993). 9-[(Phosphonoalkyl)benzyl]guanines. Multisubstrate analog inhibitors of human erythrocyte purine nucleoside phosphorylase. Journal of Medicinal Chemistry. 36(22). 3455–3463. 22 indexed citations
9.
Kelley, James L., Ed W. McLean, Mark Edelstein, et al.. (1990). Synthesis and biological activity of an acyclic analog of 5,6,7,8-tetrahydrofolic acid, N-[4-[[3-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)propyl]amino]benzoyl]-L-glutamic acid. Journal of Medicinal Chemistry. 33(2). 561–567. 24 indexed citations
10.
Kelley, James L., et al.. (1990). Benzodiazepine receptor binding activity of 8-substituted-9-(3-substituted-benzyl)-6-(dimethylamino)-9H-purines. Journal of Medicinal Chemistry. 33(1). 196–202. 24 indexed citations
11.
Kelley, James L., Ed W. McLean, R M Ferris, & James L. Howard. (1990). Benzodiazepine receptor-binding activity of 9-(1-phenylethyl)purines. Journal of Medicinal Chemistry. 33(7). 1910–1914. 14 indexed citations
12.
Kelley, James L., et al.. (1990). Synthesis of 6‐[[(hydroxyimino)phenyl]methyl]‐1‐[(1‐methylethyl)sulfonyl]‐1H‐imidazo[4,5‐b]pyridin‐2‐amine. An aza analogue of enviroxime. Journal of Heterocyclic Chemistry. 27(6). 1821–1824. 4 indexed citations
14.
Kelley, James L., Ed W. McLean, Robert M. Ferris, & James L. Howard. (1989). Benzodiazepine receptor binding activity of 6,9-disubstituted purines. Journal of Medicinal Chemistry. 32(5). 1020–1024. 20 indexed citations
15.
Kelley, James L., et al.. (1988). 9-(2-Fluorobenzyl)-6-(alkylamino)-9H-purines. A new class of anticonvulsant agents. Journal of Medicinal Chemistry. 31(5). 1005–1009. 16 indexed citations
16.
Kelley, James L., et al.. (1988). 6-(Alkylamino)-9-benzyl-9H-purines. A new class of anticonvulsant agents. Journal of Medicinal Chemistry. 31(3). 606–612. 32 indexed citations
17.
McLean, Ed W., et al.. (1981). Inhibition of Histidine Decarboxylase by Imidazole Derivatives. Journal of Pharmaceutical Sciences. 70(3). 341–343. 4 indexed citations
18.
Kelley, James L. & Ed W. McLean. (1981). Synthesis and antimicrobial testing of 2‐amino‐6‐hydroxymethyl‐4‐(3H)pyrido[3,2‐d]pyrimidinone. Journal of Heterocyclic Chemistry. 18(4). 671–673. 5 indexed citations
19.
Kelley, James L., et al.. (1977). Synthesis of bis(arylsuh'onyl)furoxans from aryl nitromethyl sulfones. Journal of Heterocyclic Chemistry. 14(8). 1415–1416. 15 indexed citations
20.
Kelley, James L., Carl A. Miller, & Ed W. McLean. (1977). Attempted inhibition of histidine decarboxylase with .beta.-alkyl analogs of histidine. Journal of Medicinal Chemistry. 20(5). 721–723. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026